Browsing: chemotherapy

Evolving Paradigms in Triple-Negative Breast Cancer Treatment: From Standard Chemotherapy to Targeted Therapies

By 0
From biomarker-driven therapies to antibody-drug conjugates, new treatments are offering more personalised and effective options for triple negative breast cancer (TNBC), an aggressive subtype of breast cancer. These innovations are helping improve survival rates and transforming how TNBC is managed, but they also come with unique challenges that require careful clinical consideration.

Log In or Register as a healthcare professional to read the full article.

Is There a Breast and Cervical Cancer Crisis in the Philippines?

By 0

Cancer remains a significant public health concern in the Philippines, with the Department of Health (DOH) recording an estimated 153,751 cases in 2020. Among the various types of cancer, breast and cervical cancers stand out as major health challenges affecting women across different demographics and regions.

Ninja Diagnosed with Cancer: A Wake-Up Call for Regular Skin Checks

By 0

Tyler “Ninja” Blevins, a 32-year-old gaming icon known for his Fortnite prowess, has revealed a personal health battle resonating across the digital world. Following a routine check-up prompted by his wife, Jessica, Ninja was diagnosed with melanoma, a potentially fatal form of skin cancer. The source was a suspicious mole discovered on the bottom of his foot.

Roche reports positive five-year survival outcomes for extensive-stage small cell lung cancer

By 0
IMbrella A, an extension of the Phase III IMpower133 study, demonstrates the potential for a durable overall survival benefit with Tecentriq plus chemotherapy in extensive-stage small cell lung cancer (ES-SCLC)
IMbrella A data build on the previously reported IMpower133 trial, which was the first clinically meaningful advance in the treatment of ES-SCLC in more than twenty years

Log In or Register as a healthcare professional to read the full article.

Bold Rescue: FDA Greenlights Unapproved Chinese Cancer Drug

By 0

In an unprecedented and strategic move, the U.S. Food and Drug Administration (FDA) has granted permission for the temporary import of an unapproved Chinese cancer drug. The decision comes amid a growing shortage of vital cancer drugs in the US, notably cisplatin, a widely used chemotherapy medication. The crisis has prompted the FDA to consider unconventional approaches, and this move stands as testament to that flexibility.